
Drs Chan and Hunter discuss asciminib in first-line CML, OPTIC trial data on ponatinib dosing, mutational testing, and stem cell transplant strategies.

Your AI-Trained Oncology Knowledge Connection!


Drs Chan and Hunter discuss asciminib in first-line CML, OPTIC trial data on ponatinib dosing, mutational testing, and stem cell transplant strategies.

ASCO has released a research statement outlining 4 recommendations to decentralize clinical trials and improve patient access to these studies.